Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2015-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1681/ASN.2013101144PMID 25125383PMCID PMC4310653
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection.

  2015cited by this paper
• Diagnosis and Management of Antibody-Mediated Rejection: Current Status and Novel Approaches

  2014cited by this paper
• Banff 2013 Meeting Report: Inclusion of C4d‐Negative Antibody‐Mediated Rejection and Antibody‐Associated Arterial Lesions

  2014cited by this paper
• Down-regulating humoral immune responses: implications for organ transplantation.

  2014cited by this paper
• Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms

  2014cited by this paper
• Complement Is Activated by IgG Hexamers Assembled at the Cell Surface

  2014cited by this paper
• Solid phase detection of C4d‐fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients

  2013cited by this paper
• The Role of Immunoglobulin-G Subclasses and C1q in De Novo HLA-DQ Donor-Specific Antibody Kidney Transplantation Outcomes

  2013cited by this paper
• Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury.

  2013cited by this paper
• Complement-binding anti-HLA antibodies and kidney-allograft survival.

  2013cited by this paper
• Preformed Complement-Activating Low-Level Donor-Specific Antibody Predicts Early Antibody-Mediated Rejection in Renal Allografts

  2013cited by this paper
• Systematic Comparison of Four Cell- and Luminex-Based Methods for Assessment of Complement-Activating HLA Antibodies

  2013cited by this paper
• Physiological and therapeutic complement regulators in kidney transplantation

  2013cited by this paper
• Antibody-mediated vascular rejection of kidney allografts: a population-based study.

  2013cited by this paper
• Donor-specific antibodies adversely affect kidney allograft outcomes.

  2012cited by this paper
• The impact of donor-specific anti-HLA antibodies on late kidney allograft failure

  2012cited by this paper
• The AJT Report: News and issues that affect organ and tissue transplantation

  2012cited by this paper
• Complement‐fixing donor‐specific antibodies identified by a novel C1q assay are associated with allograft loss

  2012cited by this paper
• Humoral immunity in chronic allograft rejection: puzzle pieces come together.

  2012cited by this paper
• Banff 2011 Meeting Report: New Concepts in Antibody‐Mediated Rejection

  2012cited by this paper
• Organ Procurement and Transplantation Network and Scientific Registry of Transplant Recipients 2010 Data Report

  2012cited by this paper
• A personal perspective: 100-year history of the humoral theory of transplantation.

  2012cited by this paper
• The role of complement in antibody-mediated rejection in kidney transplantation

  2012cited by this paper
• A Novel Pathway of Chronic Allograft Rejection Mediated by NK Cells and Alloantibody

  2012cited by this paper
• Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody‐Mediated Rejection and Nonadherence

  2012cited by this paper
• Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads.

  2011cited by this paper
• Significance of C4d Banff Scores in Early Protocol Biopsies of Kidney Transplant Recipients with Preformed Donor‐Specific Antibodies (DSA)

  2011cited by this paper
• Understanding the Causes of Kidney Transplant Failure : The Dominant Role of Antibody-Mediated Rejection and Nonadherence

  2011cited by this paper
• Diagnosis and prevention of chronic kidney allograft loss.

  2011cited by this paper
• C1q-Fixing Human Leukocyte Antigen Antibodies Are Specific for Predicting Transplant Glomerulopathy and Late Graft Failure After Kidney Transplantation

  2011cited by this paper
• Terminal Complement Inhibition Decreases Antibody‐Mediated Rejection in Sensitized Renal Transplant Recipients

  2011cited by this paper
• Long‐Term Renal Allograft Survival in the United States: A Critical Reappraisal

  2011cited by this paper
• Rejection of the kidney allograft.

  2010cited by this paper
• Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft Failure

  2010cited by this paper
• Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation.

  2010cited by this paper
• IL2 BLOCKER INDUCTION IN LIVING RELATED RENAL TRANSPLANTATION: 593

  2010cited by this paper
• Antibody‐Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure

  2009cited by this paper
• Endothelial Gene Expression in Kidney Transplants with Alloantibody Indicates Antibody‐Mediated Damage Despite Lack of C4d Staining

  2009cited by this paper
• Outcome of Subclinical Antibody‐Mediated Rejection in Kidney Transplant Recipients with Preformed Donor‐Specific Antibodies

  2009cited by this paper
• Clinical Relevance of Preformed HLA Donor‐Specific Antibodies in Kidney Transplantation

  2008cited by this paper
• Determinants of the Complement-Fixing Ability of Recipient Presensitization Against HLA Antigens

  2007cited by this paper
• Antibody and complement in transplant vasculopathy.

  2007cited by this paper
• Determinants of Poor Graft Outcome in Patients with Antibody‐Mediated Acute Rejection

  2007cited by this paper
• C4d Fixing, Luminex Binding Antibodies—A New Tool for Prediction of Graft Failure After Heart Transplantation

  2007cited by this paper
• Antibody-mediated renal allograft rejection: diagnosis and pathogenesis.

  2007cited by this paper
• Direct and Indirect Effects of Alloantibodies Link Neointimal and Medial Remodeling in Graft Arteriosclerosis

  2006cited by this paper
• Antibody-mediated organ-allograft rejection

  2005cited by this paper
• Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries.

  1999cited by this paper
• Vascular deposition of complement‐split products in kidney allografts with cell‐mediated rejection

  1991cited by this paper

• IgG Subclass Profiles of HLA Antibodies Enhance Prediction of C1q-Binding in Kidney Transplant Recipients

  2026cites this paper
• Antibody-mediated rejection—treatment standard

  2025cites this paper
• Chemotaxis overrides the killing response in alloreactive CTLs, providing vascular immune privilege during cellular rejection

  2025cites this paper
• Spanish guidelines for kidney transplantation in highly sensitized patients with donor-specific anti-HLA antibodies.

  2025cites this paper
• Functional and phenotypic profiles of HLA-specific antibodies in relation to antibody-mediated kidney transplant rejection.

  2025cites this paper
• Relevance of Human Leukocyte Antigen Class C Donor-Specific Antibodies in Kidney Transplant.

  2025cites this paper
• Characteristics of Early Antibody Mediated Rejection in Antibody Incompatible Living Donor Kidney Transplantation

  2024cites this paper
• Evolving Biomarkers in Kidney Transplantation

  2024cites this paper
• NK Cells: Not Just Followers But Also Initiators of Chronic Vascular Rejection

  2024cites this paper
• Complement and complement regulatory protein in allogeneic and xenogeneic kidney transplantation.

  2024cites this paper
• ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA Antibodies.

  2024cites this paper
• The role of antibody glycosylation in autoimmune and alloimmune kidney diseases

  2024cites this paper
• Forming a new perspective: Post‐structural approaches to determination of donor compatibility and post‐transplant assessment of allograft health

  2024cites this paper
• Association Between De Novo C1q-Binding Donor-Specific Anti-HLA Antibodies and Clinical Outcomes After Kidney Transplantation: A Meta-Analysis.

  2023cites this paper
• Subclinical rejection-free diagnostic after kidney transplantation using blood gene expression.

  2023cites this paper
• Risk factors for antibody-mediated rejection in ABO blood-type incompatible and donor-specific antibody-positive liver transplantation

  2023cites this paper
• C3d‐binding assay for the detection of complement activating HLA antibodies: A useful tool for allocation to highly sensitised recipients in the post‐CDC era?

  2023cites this paper
• The Diagnostic Significance of C3d Antigen in Kidney and Skin Histopathology - The Current State-Of-The-Art and Practical Examples.

  2023cites this paper
• Novel insights in the clinical management of hyperimmune patients before and after transplantation

  2023cites this paper
• Lung transplantation despite preformed donor-specific anti-HLA antibodies: 9-year single-center experience.

  2023cites this paper
• Complement-activating donor-specific anti-HLA antibodies in solid organ transplantation: systematic review, meta-analysis, and critical appraisal

  2023cites this paper
• Complement and Non-Complement Binding Anti-HLA Antibodies Are Differentially Detected with Different Antigen Bead Assays in Renal Transplant Recipients

  2023cites this paper
• Comparison of HLA antibody identification methods for the selection of platelet products for HLA‐mediated platelet refractory patients

  2023cites this paper
• Targeting the Complement Pathway in Kidney Transplantation.

  2023cites this paper
• Complement activation and kidney transplantation; a complex relationship.

  2023cites this paper
• On a Long and Winding Road: Alloantibodies in Organ Transplantation.

  2023cites this paper
• Role of complement in humoral immunity

  2023cites this paper
• Imlifidase for Kidney Transplantation of Highly Sensitized Patients With a Positive Crossmatch: The French Consensus Guidelines

  2023cites this paper
• Report of the 2022 Banff Heart Concurrent: Focus on Non-HLA Antibodies in Rejection and the Pathology of "Mixed" Rejection.

  2023cites this paper
• Alloimmune Risk Stratification for Kidney Transplant Rejection

  2022cites this paper
• Unraveling complexity of antibody-mediated rejections, the mandatory way towards an accurate diagnosis and a personalized treatment.

  2022cites this paper
• Complement-targeted therapies in kidney transplantation—insights from preclinical studies

  2022cites this paper
• A new flow cytometry assay identifies recipient IgG subtype antibodies binding donor cells: increasing donor availability for highly sensitised patients

  2022cites this paper
• The human cytomegalovirus-specific and UL40-mediated imprint in the natural killer cell repertoire is associated with antibody-mediated rejection in lung transplant recipients.

  2022cites this paper
• Inverted direct allorecognition triggers early donor-specific antibody responses after transplantation

  2022cites this paper
• Balancing the View of C1q in Transplantation: Consideration of the Beneficial and Detrimental Aspects

  2022cites this paper
• Microvascular Inflammation of the Renal Allograft: A Reappraisal of the Underlying Mechanisms

  2022cites this paper
• Cumulative mean fluorescent intensities of HLA specific antibodies predict antibody mediated rejections after kidney transplantation

  2022cites this paper
• Recomendaciones para el trasplante renal de donante vivo

  2022cites this paper
• Clinical Significance of C3d Assay in Kidney Transplant Recipients With Donor-Specific Anti-Human Leukocyte Antigen Antibodies.

  2022cites this paper
• Role of Complement System in Kidney Transplantation: Stepping From Animal Models to Clinical Application

  2022cites this paper
• Evolution of humoral lesions on follow-up biopsy stratifies the risk for renal graft loss after antibody-mediated rejection treatment.

  2022cites this paper
• De Novo Complement-Binding Anti-HLA Antibodies in Heart Transplanted Patients Is Associated with Severe Cardiac Allograft Vasculopathy and Poor Long-Term Survival

  2022cites this paper
• Complement-Binding Donor-Specific Anti-HLA Antibodies: Biomarker for Immunologic Risk Stratification in Pediatric Kidney Transplantation Recipients

  2022cites this paper
• Intra-Liver Allograft C3d-Binding Donor-Specific Anti-HLA Antibodies Predict Rejection After Liver Transplantation.

  2022cites this paper
• Can Gene Expression Analysis in Zero-Time Biopsies Predict Kidney Transplant Rejection?

  2022cites this paper
• Extracellular vesicles derived from patients with antibody‐mediated rejection induce tubular senescence and endothelial to mesenchymal transition in renal cells

  2022cites this paper
• Recommendations for living donor kidney transplantation.

  2022cites this paper
• De novo donor-specific HLA antibodies reduce graft survival rates and increase the risk of kidney transplant rejection: A single-center retrospective study.

  2021cites this paper
• Complement Components in the Diagnosis and Treatment after Kidney Transplantation—Is There a Missing Link?

  2021cites this paper
• Aberrant activation of complement system in renal grafts is mediated by cold storage.

  2021cites this paper
• Allograft recognition by recipient's natural killer cells: Molecular mechanisms and role in transplant rejection

  2021cites this paper
• Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection

  2021cites this paper
• Therapies for Chronic Allograft Rejection

  2021cites this paper
• Innate (and Innate-like) Lymphoid Cells: Emerging Immune Subsets With Multiple Roles Along Transplant Life

  2021cites this paper
• Intensity of de novo DSA detected by Immucor Lifecodes assay and C3d fixing antibodies are not predictive of subclinical ABMR after Kidney Transplantation

  2021cites this paper
• Cellular and Molecular Crosstalk of Graft Endothelial Cells During AMR: Effector Functions and Mechanisms

  2021cites this paper
• An activated endothelium after organ transplantation: the pathogenesis of rejection

  2021cites this paper
• Post-transplant de novo non donor-specific HLA antibodies are not associated with poor graft outcome in non-sensitized pediatric recipients of kidney transplantation.

  2021cites this paper
• Kidney transplantation in highly sensitized recipients

  2021cites this paper
• Diagnostic Dilemma: Glomerular Linear IgG Deposit with Negative Anti-GBM Antibody

  2021cites this paper
• Allorecognition and the spectrum of kidney transplant rejection.

  2021cites this paper
• IgG3 donor–specific antibodies with a proinflammatory glycosylation profile may be associated with the risk of antibody‐mediated rejection after kidney transplantation

  2021cites this paper
• Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.

  2021cites this paper
• Solid-Phase C1q/C3d Fixing Readouts Correlate with High Median Fluorescence Intensity (MFI) De Novo Donor-Specific HLA Antibodies and C4d+ Antibody-Mediated Rejection in Kidney Transplant Recipients

  2021influential citation
• 30 years of the International Banff Classification for Allograft Pathology: The Past, Present and Future of Kidney Transplant Diagnostics.

  2021cites this paper
• Choosing the Right Patient for Lung Transplantation: Assessment of Histocompatibility and Sensitization Status

  2021cites this paper
• Unconventional T cells and kidney disease

  2021cites this paper
• Defining Clinically Pathogenic HLA-Specific Antibodies - Granular Details in Characteristics in Pre and Early Time Following HLA-Antibody Incompatible Kidney Transplantation

  2021cites this paper
• Missing Self–Induced Microvascular Rejection of Kidney Allografts: A Population-Based Study

  2021cites this paper
• C1q binding to surface-bound IgG is stabilized by C1r2s2 proteases

  2021cites this paper
• Tocilizumab in the Treatment of Chronic Antibody-Mediated Rejection Post Kidney Transplantation: Clinical and Histological Monitoring

  2021cites this paper
• Approaches for the characterization of clinically relevant pre‐transplant human leucocyte antigen (HLA) antibodies in solid organ transplant patients

  2021cites this paper
• Correlation Between C3d Assay and Single Antigen Bead Assay for Detection of Human Leukocyte Antigen Class II Antibodies

  2020cites this paper
• Clinical relevance of donor‐specific antibodies directed at HLA‐C: A long road to acceptance

  2020cites this paper
• La historia de un trasplante renal previo es el evento más importante para identificar subclases de IgG de los anticuerpos anti-HLA y positividad del ensayo C3d

  2020cites this paper
• Novel Diagnostic and Therapeutic Approach to Antibody-Mediated Rejections in Heart Transplantation

  2020cites this paper
• C1q‐binding DSA and allograft outcomes in pediatric kidney transplant recipients

  2020cites this paper
• History of a previous renal transplant as the most important event for C3d positive HLA antibodies and IgG subclass identification

  2020cites this paper
• Investigating complement mediated interference in class I HLA-specific antibodies following renal transplantation.

  2020cites this paper
• Monitoring of Donor-specific Anti-HLA Antibodies and Management of Immunosuppression in Kidney Transplant Recipients: An Evidence-based Expert Paper.

  2020cites this paper
• Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction.

  2020cites this paper
• Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report

  2020cites this paper
• Humoral Alloreactivity in VCA Recipients: Should We Learn From Our Experience?

  2020cites this paper
• Alloantibodies and Platelets

  2020cites this paper
• C3d‐positive donor‐specific antibodies have a role in pretransplant risk stratification of cross‐match‐positive HLA‐incompatible renal transplantation: United Kingdom multicentre study

  2020cites this paper
• Immunological Characteristics and Management of Kidney Transplantation

  2020cites this paper
• Anti-donor antibody induction following intramuscular injections of mesenchymal

  2020cites this paper
• C3d-Positive Preformed DSAs Tend to Persist and Result in a Higher Risk of AMR after Kidney Transplants

  2020cites this paper
• [Missing self-induced NK cell activation promotes "innate" chronic vascular rejection of transplanted organs].

  2020cites this paper
• Highly Variable Sialylation Status of Donor-Specific Antibodies Does Not Impact Humoral Rejection Outcomes

  2019cites this paper
• Detecting donor-specific antibodies: the importance of sorting the wheat from the chaff.

  2019cites this paper
• Donor-Specific Antibodies in the Absence of Rejection Are Not a Risk Factor for Allograft Failure

  2019cites this paper
• Results and reflections from the PROfiling Consortium on Antibody Repertoire and Effector functions in kidney transplantation: A mini‐review

  2019cites this paper
• Costimulatory blockade molecules and B-cell-mediated immune response: current knowledge and perspectives.

  2019cites this paper
• Biomarkers of rejection in kidney transplantation.

  2019cites this paper
• Donor-Specific HLA Antibodies as Biomarkers of Transplant Rejection.

  2019cites this paper
• Allograft rejection is associated with development of functional IgE specific for donor MHC antigens

  2019cites this paper
• HLA and lung transplantation

  2019cites this paper
• Residual Activatability of Circulating Tfh17 Predicts Humoral Response to Thymodependent Antigens in Patients on Therapeutic Immunosuppression

  2019cites this paper